Inventor · disambiguated record
Noriko Nunami
Also filed as: NUNAMI NORIKO
5 granted patents·4 pending applications·41 citations·filing 2002–2013
76Inventor score
Technology areasA61P
Files withAXIKIN PHARMACEUTICALS INC3BAYER HEALTHCARE AG2LI YINGFU2DAINIPPON SUMITOMO PHARMA CO1MURATA TOSHIKI1
Top patents by PatentIndex Score
9 records- 0183US7674797B22-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disordersAXIKIN PHARMACEUTICALS INC·Filed 2004·Granted Mar 9, 2010·20 cites·10 claims
- 0281US7700586B2Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disordersAXIKIN PHARMACEUTICALS INC·Filed 2002·Granted Apr 20, 2010·19 cites·19 claims
- 0374US9206186B22-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disordersAXIKIN PHARMACEUTICALS INC·Filed 2013·Granted Dec 8, 2015·2 cites·7 claims
- 0457US2009286771A12-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological DisordersLI YINGFU·Filed 2009·Application pending·0 cites
- 0554US2009054424A1Optically active pyridine derivative and a medicament containing the sameMURATA TOSHIKI·Filed 2008·Application pending·0 cites
- 0651US7375103B2Optically active pyridine derivative and a medicament containing the sameBAYER HEALTHCARE AG·Filed 2003·Granted May 20, 2008·0 cites·6 claims
- 0746US2005222247A1Chroman derivativesBAYER HEALTHCARE AG·Filed 2004·Application pending·0 cites
- 0842US2011071289A1Aminopyrazole amide derivativeDAINIPPON SUMITOMO PHARMA CO·Filed 2008·Application pending·0 cites
- 0938US8242118B2Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disordersLI YINGFU·Filed 2010·Granted Aug 14, 2012·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Noriko Nunami files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →